Altria (MO) filed its fiscal year 2025 10-K annual report with the SEC on Feb 25, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • U.S.-focused tobacco portfolio (cigarettes, cigars, MST, oral pouches, e-vapor) sold primarily to domestic wholesalers and retailers
- • Horizon joint venture (75% Altria / 25% Japan Tobacco) established for U.S. HTS commercialization; no products yet in marketplace as of Feb 2026
Management Discussion & Analysis
- • Net revenues $23.3B, down $739M (3.1%) YoY; smokeable products drove decline at $20.5B vs $21.2B
- • Reported net earnings fell 38.3% to $6.95B ($4.12 diluted EPS); adjusted net earnings $9.15B, up 2.4%, adjusted EPS $5.42 vs $5.19
Risk Factors
- • ITC-imposed import ban on NJOY ACE (patent suit by JUUL), forced product removal; additional JUUL suit pending over NJOY Daily
- • Nicotine extract for innovative smoke-free products sourced from a single country; no alternate source identified
Financial SummaryXBRL
Revenue
$23.3B
Net Income
$6.9B
Gross Margin
62.5%
Operating Margin
42.5%
Net Margin
29.8%
ROE
-198.4%
Total Assets
$35.0B
EPS (Diluted)
$4.12
Operating Cash Flow
$9.3B
Source: XBRL data from Altria FY2025 10-K filing on SEC EDGAR. All figures in USD.
Other Altria Annual Reports
Get deeper insights on Altria
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.